Sep. 10 2026
Source Page: Letter dated 07/09/2026 from Lord Coaker to Peers regarding the Future Capability of the Armed Forces debate follow up. 6p.Sep. 10 2026
Source Page: Letter dated 09/09/2026 from Lord Coaker to Baroness Goldie regarding the Armed Forces Bill committee stage debate (first day): question in relation to amendment 35: Court Martials and senior officers. 2p.Sep. 09 2026
Source Page: Letter dated 26/08/2026 from Lord Coaker to Baroness Brinton regarding the protection and support of victims, and the case involving US Air Force officer Jacob Wulfson, as discussed during the Second Reading of the Armed Forces Bill. 3p.Sep. 09 2026
Source Page: Letter dated 28/08/2026 from Satvir Kaur MP to Karen Bradley MP regarding some of the measures the Home Office have taken forward to halve violence against women in a decade and help make communities safer. 2p.Sep. 09 2026
Source Page: Letters dated 03/09/2026 and 02/09/2026 from Katherine Braddick, Deputy Governor and CEO, Prudential Regulation Authority, and Nikhil Rathi, Chief Executive, Financial Conduct Authority, to Lord Pitt-Watson regarding the Financial Services and Markets Bill 2026: PRA and FCA accountability, scrutiny and proportionality. 2 docs.Sep. 09 2026
Source Page: Letters dated 03/09/2026 and 02/09/2026 from Katherine Braddick, Deputy Governor and CEO, Prudential Regulation Authority, and Nikhil Rathi, Chief Executive, Financial Conduct Authority, to Lord Pitt-Watson regarding the Financial Services and Markets Bill 2026: PRA and FCA accountability, scrutiny and proportionality. 2 docs.Sep. 02 2026
Source Page: I. Letter dated 19/08/2026 from Sarah Jones MP to Karen Bradley MP regarding consultation on tightening controls on Gamma-Butyrolactone and 1, 4-Butanediol. II. The control of Gamma-Butyrolactone (GBL) and 1,4-Butanediol (1,4-BD). Government consultation. Home Office; Department of Health Northern Ireland. 28p.Sep. 02 2026
Source Page: I. Letter dated 19/08/2026 from Sarah Jones MP to Karen Bradley MP regarding consultation on tightening controls on Gamma-Butyrolactone and 1, 4-Butanediol. II. The control of Gamma-Butyrolactone (GBL) and 1,4-Butanediol (1,4-BD). Government consultation. Home Office; Department of Health Northern Ireland. 28p.Aug. 28 2026
Source Page: I. Small Modular Reactor Programme - Technology Partner Contract. Accounting Officer Assessment. 3p. II. Technology Partner: summary full business case. 10p. III. Small Modular Reactor Owner’s Engineer: summary business case. 5p. IV. Letter dated 17/08/2026 from Michael Shanks MP to Bill Esterson MP regarding the publication of three documents associated with Great British Energy - Nuclear (GBE-N) SMR Programme. 2p. V. Letter dated 17/08/2026 from Michael Shanks MP to the Deposited Papers Clerk regarding three documents for deposit in the House libraries. 1p.Aug. 28 2026
Source Page: I. Small Modular Reactor Programme - Technology Partner Contract. Accounting Officer Assessment. 3p. II. Technology Partner: summary full business case. 10p. III. Small Modular Reactor Owner’s Engineer: summary business case. 5p. IV. Letter dated 17/08/2026 from Michael Shanks MP to Bill Esterson MP regarding the publication of three documents associated with Great British Energy - Nuclear (GBE-N) SMR Programme. 2p. V. Letter dated 17/08/2026 from Michael Shanks MP to the Deposited Papers Clerk regarding three documents for deposit in the House libraries. 1p.